The following is a summary of “Mitochondrial Metabolism Gene ECH1 Was Identified as a Novel Biomarker for Diabetic ...

People with type 2 diabetes who regularly use the supplement glucosamine have a lower risk for microvascular complications ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

The global dialysis device and concentrates market is poised for significant expansion, forecasted to grow from USD 23,690.3 million in 2025 to USD 79,224.7 million by 2035, representing a steady CAGR ...

Frequent consumption of bubbly and sugary drinks could be a contributing factor for any number of reasons that damage kidney ...

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused ...

Mesoblast Limited’s MESO share price has surged by 5.14%, which has investors questioning if this is right time to sell.